Avoid common mistakes on your manuscript.
1 Correction to: Drugs (2021) 81:587–594 https://doi.org/10.1007/s40265-021-01481-6
Page 3, Table 2 , ‘Complete TMA response’ section:
“Serum creatinine ≥ 25% ↑ from BLb (% pts) [95% CI]”
Should read:
“Serum creatinine ≥ 25% improvement from BLb (% pts) [95% CI]”
Page 3, Table 2 , foot note ‘b’:
“bComponent of complete TAM response”
Should read:
“bComponent of complete TMA response”
The corrected Table 2 is as follows:
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Syed, Y.Y. Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome. Drugs 81, 1363–1364 (2021). https://doi.org/10.1007/s40265-021-01563-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-021-01563-5